ACIM
BMY icon

Azimuth Capital Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Azimuth Capital Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.29M Buy
120,157
+2,390
+2% +$139K 0.27% 120
2025
Q4 		$6.35M Buy
117,767
+12,425
+12% +$598K 0.23% 130
2025
Q3 		$4.75M Buy
105,342
+5,090
+5% +$238K 0.17% 144
2025
Q2 		$4.64M Sell
100,252
-10,528
-10% -$517K 0.17% 150
2025
Q1 		$6.76M Sell
110,780
-725
-0.7% -$42.3K 0.27% 122
2024
Q4 		$6.31M Buy
111,505
+60
+0.1% +$3.35K 0.25% 127
2024
Q3 		$5.77M Sell
111,445
-1,280
-1% -$60K 0.22% 136
2024
Q2 		$4.68M Sell
112,725
-6,562
-6% -$294K 0.19% 149
2024
Q1 		$6.47M Sell
119,287
-7,724
-6% -$393K 0.27% 128
2023
Q4 		$6.52M Sell
127,011
-3,351
-3% -$176K 0.29% 116
2023
Q3 		$7.57M Buy
130,362
+1,240
+1% +$76K 0.37% 90
2023
Q2 		$8.26M Sell
129,122
-3,895
-3% -$261K 0.39% 87
2023
Q1 		$9.22M Sell
133,017
-1,085
-0.8% -$76.5K 0.45% 72
2022
Q4 		$9.65M Sell
134,102
-1,605
-1% -$121K 0.49% 65
2022
Q3 		$9.65M Sell
135,707
-395
-0.3% -$28.7K 0.53% 59
2022
Q2 		$10.5M Buy
+136,102
New +$10.4M 0.53% 62

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Azimuth Capital Investment Management's BMY Position: Q1 2026 in Review

Azimuth Capital Investment Management increased its Bristol-Myers Squibb (BMY) stake by 2% in Q1 2026, buying an estimated $139K and bringing the position to 120,157 shares worth $7.29M. The position accounts for 0.27% of the portfolio, ranked #120.

Azimuth Capital Investment Management first reported a position in BMY in Q2 2022 and has held it in 16 quarters since. The position peaked at $10.5M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Azimuth Capital Investment Management held 120,157 shares of Bristol-Myers Squibb worth $7.29M as of Q1 2026.
  • Azimuth Capital Investment Management bought 2,390 Bristol-Myers Squibb shares in Q1 2026, an estimated $139K.
  • Bristol-Myers Squibb made up 0.27% of Azimuth Capital Investment Management's portfolio in Q1 2026, its #120 holding.
  • Azimuth Capital Investment Management first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 16 quarters since.
  • Azimuth Capital Investment Management's Bristol-Myers Squibb position peaked at $10.5M in Q2 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q1 2026, filed 12 May 2026.